InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Saturday, 12/03/2016 10:06:51 AM

Saturday, December 03, 2016 10:06:51 AM

Post# of 345786
DTRA budget cut back in 2008... sabotage comes in many forms (notice first line says Agency confirms it has interest in anti-PS for bio defense applications ...)
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=281980

But now....all is well when Roche involved and Dr Richard Hatchett...
https://www.hhs.gov/about/news/2016/09/21/hhs-forges-strategic-partnerships-companies-develop-antibiotics.html

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News